What You Should Know about Apple Cider Vinegar Supplements Consumer News What You Should Know about Apple Cider Vinegar Supplements TINA.org explores the divide between the marketing and the science.
Monetizing Minors: Piper Rockelle Consumer News Monetizing Minors: Piper Rockelle A calorie-counting app is just one of the adult products promoted on this minor’s social media channels.
Proposed Glucosamine Settlement Stiffs Consumers Consumer News Proposed Glucosamine Settlement Stiffs Consumers Class-action settlement over supplement sold by Walmart, Walgreens and Supervalu provides little relief to consumers.
Vemma Reaches $238 Million Settlement with FTC Consumer News Vemma Reaches $238 Million Settlement with FTC Company agrees to a ban on pyramid scheme practices to settle charges.
Proposed Settlement Allows for Continued Deceptive Marketing of Neuriva Consumer News Proposed Settlement Allows for Continued Deceptive Marketing of Neuriva TINA.org files brief urging court to deny final approval of settlement that is unfair to consumers.
TINA’s Take: Supplement Maker Sued for Alleged ‘Review Hijacking’ on Amazon Consumer News TINA’s Take: Supplement Maker Sued for Alleged ‘Review Hijacking’ on Amazon Company to pay $600,000 for allegedly manipulating product pages.
Coronavirus Spawns Class-Action Lawsuits as Consumers Seek Refunds Consumer News Coronavirus Spawns Class-Action Lawsuits as Consumers Seek Refunds The pandemic has also triggered lawsuits over privacy issues with some video conferencing apps, and more.
Cold Products Pay Millions for Misleading Consumers Consumer News Cold Products Pay Millions for Misleading Consumers Unproven cold prevention and treatment claims are nothing to sneeze at.
FDA Heeds Our Concerns and Bans DMAA Products Consumer News FDA Heeds Our Concerns and Bans DMAA Products Agency prohibits products with DMAA from entering market.
TINA.org Renews Effort on Deceptively Marketed Supplement Consumer News TINA.org Renews Effort on Deceptively Marketed Supplement European agency rules that marketing of formula is misleading.
SevenPoint2 & CEO Boreyko Violating FTC Order Consumer News SevenPoint2 & CEO Boreyko Violating FTC Order Alkaline MLM’s health claims add up to FTC consent order violations.
TAKEDOWN: Feds Move against Vemma Consumer News TAKEDOWN: Feds Move against Vemma FTC alleges Vemma is a pyramid scheme and freezes assets.
Wellesse Glucosamine Settlement Doesn’t Cure Ad Issues Consumer News Wellesse Glucosamine Settlement Doesn’t Cure Ad Issues TINA.org, continuing its efforts to oppose unfair settlements, files an objection.
TINA’s Take: Up Close with some Goopy Health Claims Consumer News TINA’s Take: Up Close with some Goopy Health Claims In whose health? We sum up some suspect claims at the In Goop Health inaugural wellness summit.
FTC Shuts Down Marketing of Supplements on Fake Radio Talk Show Consumer News FTC Shuts Down Marketing of Supplements on Fake Radio Talk Show Claims about efficacy of supplements and undisclosed paid endorsers at issue.
Prevagen Scrubs Memory-Improvement Claims Following Court Order Consumer News Prevagen Scrubs Memory-Improvement Claims Following Court Order What led up to brain supplement’s December to remember.
LifeVantage Faces Pyramid Scheme Lawsuit Consumer News LifeVantage Faces Pyramid Scheme Lawsuit “False dreams of wealth” are touted in an attempt to make up for products that are “snake oil,” complaint alleges.
Are Homeopathic Drugs Misleading Consumers? Consumer News Are Homeopathic Drugs Misleading Consumers? FDA revisits a decades-old policy that essentially allows homeopathic drugs to go unchecked into the marketplace.
Glucosamine Settlement Is a Raw Deal for Consumers Consumer News Glucosamine Settlement Is a Raw Deal for Consumers TINA.org objects to proposed settlement in which marketer and plaintiffs’ attorneys are the only winners.
TINA.org to FTC: Prevagen is Making Unsupported Memory Claims Consumer News TINA.org to FTC: Prevagen is Making Unsupported Memory Claims Investigation finds no competent evidence to support memory improvement claims and FTC files a lawsuit.